Chemoinformaics analysis of p-((p-(Heptylamino)phenyl)azo)benzenearsonic acid
| Molecular Weight | 419.357 | nRot | 10 |
| Heavy Atom Molecular Weight | 393.149 | nRig | 2 |
| Exact Molecular Weight | 419.119 | nRing | 2 |
| Solubility: LogS | -1.816 | nHRing | 0 |
| Solubility: LogP | 2.539 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 59.0826 |
| nHD | 3 | BPOL | 39.2214 |
| QED | 0.442 |
| Synth | 2.401 |
| Natural Product Likeliness | 1.683 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.007 |
| HIA | 0.004 |
| CACO-2 | -4.191 |
| MDCK | 0.0000352 |
| BBB | 0.995 |
| PPB | 0.453286 |
| VDSS | 0.953 |
| FU | 0.621738 |
| CYP1A2-inh | 0.902 |
| CYP1A2-sub | 0.143 |
| CYP2c19-inh | 0.155 |
| CYP2c19-sub | 0.601 |
| CYP2c9-inh | 0.034 |
| CYP2c9-sub | 0.655 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.301 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.227 |
| CL | 7.768 |
| T12 | 0.823 |
| hERG | 0.015 |
| Ames | 0.026 |
| ROA | 0.036 |
| SkinSen | 0.922 |
| Carcinogencity | 0.719 |
| EI | 0.992 |
| Respiratory | 0.071 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.678803 |